Author: Crijns Ineke
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.12, Iss.1, 2013-01, pp. : 29-38
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Teichert Martina Visser Loes E. Dufour Mark
Drug Safety, Vol. 33, Iss. 4, 2010-04 ,pp. :
US FDA strengthens isotretinoin risk management programme
Inpharma, Vol. 1, Iss. 1501, 2005-01 ,pp. :